Douglas Holt
@DouglasHoltMDRadiation Oncologist - Idaho Cancer Center | Improving Patient Experience | Virtual Reality for Patient Ed | https://t.co/vb8eaOgC3o - Video Distraction
Similar User
@AmishiBajajMD
@MarkMishraMD
@radoncadonk1
@PagingDrPage
@nataliezumab
@allisongardaMD
@snseyedinMD
@EliDScher
@b_fischervaluck
@EmileGogineni
@DrHut10
@BismarckOdeiMD
@JAMRadOnc
@yoonie_verse
kdvr.com/news/local/new… RadFlix - co-developed with @BWMolinero, thanks for support of @SarahMilgrom & @BK_radiation for this project, as our mission is to improve the patient experience in a meaningful way. Excited for the publicity from @uchealth @kevinltorres @PRJessDenver
Congrats to all authors for the new ESTRO-EANO guideline on target delineation and radiotherapy for IDHmutant WHO CNS grade 2 and 3 diffuse glioma - Radiotherapy and Oncology @EANOassociation @ESTRO_RT @MaxNiyazi thegreenjournal.com/article/S0167-…
#WorldArthritisDay @RadioterapiaHM experience: 260 patients with OSTEOARTHRITIS underwent low-dose radiotherapy #LDRT After 🔟 years of FU: - 2/3 of patients remain pain and functionalitiy benefit 🏃♂️ - 40% need less 💊 - NO TOXICITY ☢️ #LDRT is safe and effective for OA!
❗️ Phase 3 RCT oligomet NSCLC EGFRm -> TKI +/- 60 Gy PFS HR 0.57; P = .004 OS HR 0.62; P = .029 mOS 26.2 vs 34.4 mos More data supporting aggressive RT in oligomet disease! ascopubs.org/doi/10.1200/JC…
🚨 First Modern American Study on LDRT for Osteoarthritis At @ASTRO_org , we presented the first modern American study to explore the effectiveness of low-dose radiotherapy (LDRT) in alleviating pain for osteoarthritis patients. ❇ Conducted at the Leonard C. Ferguson Cancer…
Another great oral presentation at #ARS2024. Our @MDAndersonNews #RadOnc PGY4 resident @MichaelRooney67 gave a compelling talk on the role of RT dose to the anterior vaginal wall as a predictor of sexual pain after chemoRT for Anal cancer. Take home message- keep the V35 < 60%!!
As always, I'll take this chance hit the replay button on my love of Xofigo. It took less than a year to update my rural hospital's NRC license and start a program from scratch - and obviously, most of that was just waiting for paperwork (lol).
Calling all #RLT fans. Amazing data presented by @Silke_Gillessen bringing back an oldie but a goodie. Large phase 3 PEACE3 results showing OS benefit with #radium223 without significant increase in toxicity in the frontline mCRPC setting.
Dear colleagues, please help me remember whose slide this is so I can give appropriate attribution in future talks. It's a contemporary masterpiece. #radonc @IyengarPuneeth @Jbauml @drdavidpalma @fifimcdrmh @CJTsaiMDPhD
🚨 New Insights into Patterns of Locoregional Recurrence in #PancreaticCancer after TNT & Their Impact on Neoadjuvant RT Volumes 🚨 pubmed.ncbi.nlm.nih.gov/39182645/ #PancSM #Radonc 🙌 @SaraBelPonMD n=1/8
Case Report: Role of Boswellia Serrata in Management of CNS Radiation Necrosis After Radiosurgery for Brain Metastases 🔗 bit.ly/48mCy6n #RadOnc #RadOncEd #MedEd #CaseReport
Hot off the press in @IJROBP: the ARREST phase I trial of SABR in poly-metastatic disease, led by @lhscradonc & @TimkWin Average number of lesions = 16 Dose safely escalated to 30 Gy in 5 fractions. sciencedirect.com/science/articl… The phase II/III RCT ARREST2 is underway!
Practical Considerations for the Treatment of an Adrenal Metastasis With Stereotactic Body Radiation Therapy - Practical Radiation Oncology practicalradonc.org/article/S1879-…
🚨Need for Formal Education in Treating Benign Conditions with Radiotherapy🚨 The field of radiation oncology is rapidly evolving, with a growing demand for radiotherapy to treat benign diseases. However, many radiation oncologists lack comprehensive training in this area.…
Improving symptom palliation in pancreas cancer critical. Great presentation by Dr. Chiorean. Wanted to add celiac SBRT as option – multiple studies showing high efficacy rates w 25 Gy x 1 (Yaacov Lawrence) or 8 Gy x 3 (PAINPANC trial) Also now in 2024 NCCN guidelines! #ASCO24
We really need to lobby hard to get SBRT into NCCN guides as Cat 1 in all the areas where we have RCT’s (which is more and more)
Really important study highlighting the AEs from SpaceOAR, including 5 mortalities Our editorial that accompanied the @JackMillot_ publication in @urogoldjournal goldjournal.net/article/S0090-… #AUA24 @urotoday @Barrigel_spacer @teleflex
1/ Next up NARLA2 #LUNGCANCER trial at #ESTRO24🔥🔥🔥 PET guided dose escalation phase III (because 60-66 Gy is not high enough for many tunors‼️)
Improved locoregional control with PET-guided inhomogeneous dose escalation in locally advanced NSCLC! 😍 The NARLAL2 trial randomised 350 pt to 66Gy/33# or up to ~94Gy boost. Locoregional control: 50% vs 60% at 24m. No increased toxicity! #ESTRO24 #radonc #NSCLC
Just published in @TheLancet Oncology: Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma — an ESTRO study endorsed by EAU. 👉 Read the summary: bit.ly/3Wtqb5Y @Uroweb
Design and main results: 🚩MDT vs ENRT, both arms 6mo of ADT 🚩Higher GU2+ tox in ENRT arm, but mainly due to more prostate bed RT in this arm 🚩Omitting PB RT results in higher rate of local failures 🚩Locoregional control superior with ENRT: 90% control @ 3yr. 🏴MFS not mature
United States Trends
- 1. Happy Thanksgiving 547 B posts
- 2. $cuto 6.247 posts
- 3. Thankful 235 B posts
- 4. Turkey Day 27,9 B posts
- 5. #Gratitude 8.502 posts
- 6. #Grateful 4.614 posts
- 7. Al Roker N/A
- 8. Feliz Día de Acción de Gracias 2.248 posts
- 9. Jimmy Fallon 1.300 posts
- 10. Vindman 96,8 B posts
- 11. Death Becomes Her N/A
- 12. The Outsiders 2.274 posts
- 13. #Butter1BillionOnYT 15,2 B posts
- 14. Hoda 1.075 posts
- 15. #GiveThanks 1.591 posts
- 16. Gobble Gobble 14,4 B posts
- 17. #AskZB N/A
- 18. Go Lions N/A
- 19. Michelle Williams N/A
- 20. Cutoshi N/A
Who to follow
-
Amishi Bajaj, MD
@AmishiBajajMD -
Mark V. Mishra
@MarkMishraMD -
Benjamin Onderdonk
@radoncadonk1 -
Brandi Page
@PagingDrPage -
Natalie Ridge, DO, MS (she/her)
@nataliezumab -
Allison Garda
@allisongardaMD -
Steven Seyedin
@snseyedinMD -
Eli Scher
@EliDScher -
Ben Fischer-Valuck
@b_fischervaluck -
Emile Gogineni
@EmileGogineni -
Ryan Hutten, MD
@DrHut10 -
Bismarck Odei MD
@BismarckOdeiMD -
Joseph A. Miccio, MD
@JAMRadOnc -
Stephanie Yoon
@yoonie_verse
Something went wrong.
Something went wrong.